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ABSTRACT
Background: Mirizzi syndrome is a rare complication of
cholecystolithiasis characterized by jaundice due to com-
pression of the common hepatic duct. The diagnosis may
not be immediately apparent, and management is contro-
versial with open surgery still recommended by some
authors.
Method: A case is detailed herein of a 67-year-old man
who presented with abdominal pain, fever, and jaundice.
A dilated bile duct was found on ultrasound, but the
gallbladder could not be seen. The diagnosis of Mirizzi
syndrome was made at ERCP, and a stent was placed
through the papilla. Laparoscopic retrograde (fundus first)
cholecystectomy was carried out utilizing a laparoscopic
liver retractor.
Results: In this particular case, it was not possible at ERCP
to get a guidewire and stent past the obstruction. A stent
was left through the papilla, below the obstruction and
this allowed primary duct closure during surgery.
Conclusion: Acute Mirizzi syndrome should be sus-
pected when a patient presents with acute cholecystitis
and jaundice with dilated intrahepatic ducts on ultra-
sound. ERCP is useful to confirm the diagnosis and allows
stenting to alleviate the jaundice and facilitate the subse-
quent operation. Laparoscopic ultrasound is useful to lo-
cate the impacted stone and to partially replicate the touch
of the surgeon’s hand, which is not available in laparo-
scopic surgery.
Key Words: Mirizzi syndrome, Laparoscopic cholecystec-
tomy, ERCP.
INTRODUCTION
Mirizzi syndrome (MS) is biliary obstruction from com-
pression of the common hepatic duct (CHD) by a gall-
stone impacted in the cystic duct. McSherry1 classified the
syndrome into 2 groups: type I where extrinsic compres-
sion of the bile duct occurs and type II where erosion
occurs of the wall of the CHD by the stone with formation
of a cholecysto-choledochal fistula. Csendes2 further sub-
divided type II depending on the size of the fistula and the
degree of destruction of the wall of the CHD.
The syndrome was initially described in 1948 by Pablo
Luis Mirizzi,3 Professor of Surgery in Cordoba, Argentina,
and he erroneously postulated that the extrinsic pressure
and inflammation induced spasm of the CHD. Patients
with MS classically present with biliary type pain and
obstructive jaundice. Precise diagnosis may be difficult
initially because the condition may be confused with cho-
ledocholithiasis and cholangitis. The classical ultrasound
findings are of a contracted gallbladder, dilated intrahe-
patic ducts, and a normal common bile duct (CBD).
Although a rare condition, many controversial aspects still
surround the definition and management of MS. To illus-
trate the true MS and the value of a combination of
endoscopic retrograde cholangiopancreatography (ERCP)
and laparoscopic surgery, a case is presented herein of
acute MS type I.
CASE REPORT
A 67-year-old man was admitted to the Emergency De-
partment with a 3-day history of gradually worsening
upper abdominal pain associated initially with vomiting
and anorexia. The patient had a history of hypertension
and polymyalgia rheumatica. He was noted to be jaun-
diced with a temperature of 38° Celsius and right upper
quadrant tenderness and guarding. His white blood cell
count and serum lipase were normal. His liver function
tests were markedly deranged with bilirubin 106 mol/L
[range, 3 to 22], alkaline phosphatase 159 IU/L (range, 20
to 110), and alanine transaminase 770 IU/L (range, 5 to
65). A diagnosis of cholangitis was made and ultrasound
arranged. This showed dilated intrahepatic ducts with the
CBD reported as also being dilated and measuring 9mm in
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CASE REPORTdiameter. Neither the gallbladder nor any stones were
seen. Subsequent imaging showed that the ultrasound had
actually detected a dilated CHD as the CBD was not
dilated.
At ERCP, contrast filled a nondilated CBD up to an ob-
struction due to a stone (Figure 1). Attempts were made
to pass a guidewire beyond the obstruction up into the
CHD and intrahepatic ducts but without success. The
guidewire kept going into the gallbladder, and it became
apparent that there was an MS with the obstructing stone
in the cystic duct causing compression of the CHD (Fig-
ure 2). After the guidewire had been manipulated for a
time, some pus came out of the papilla signifying a gall-
bladder empyema. A 10 French straight plastic stent was
placed through the papilla without papillotomy with its
proximal tip lying below the obstruction and, as expected,
no bile or intrahepatic contrast drained.
A computed tomogram (CT) scan was done and showed
a contracted gallbladder with a calcified stone causing
biliary obstruction (Figure 3). At laparoscopic cholecys-
tectomy, an acutely inflamed, shrunken gallbladder was
found, and a retrograde or “fundus first” dissection was
carried out. A liver retractor was used to elevate the liver
and maintain exposure of the bile duct (Diamond-Flex,
Cardinal Health, Snowden-Dencer MIS Products, Tucker,
GA, USA) (Figure 4). It was possible to “feel” the stone
via a grasper, and its position was definitely confirmed by
laparoscopic ultrasound (Figure 5). The duct was incised
to release the impacted stone with a single-use CBD blade
(Espiner Medical Ltd. Bristol, UK. www.espinermedical.
com) (Figure 6). The CBD was examined with a 5-mm
flexible choledochoscope showing that the duct was clear
distally with the stent in place (Figure 7). It was not
possible to retroflex the choledochoscope to examine the
Figure 2. ERCP confirming Mirizzi syndrome with the guidewire
in the gallbladder (GB). The stone is impacted in the cystic duct,
which is anterior and parallel to the common hepatic duct. Note
the narrow common bile duct and the dilatation of the common
hepatic and intrahepatic ducts.
Figure 1. ERCP showing a stone (arrow) obstructing the bile
duct.
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was excised, the opening in the cystic duct sutured with
continuous 4–0 Vicryl (Ethicon Inc., Somerville, NJ, USA)
and a 20 French nonsuction tube drain placed in the
subhepatic space near the bile duct. This drained 100mL
to 200mL of bile stained fluid for several days. The patient
was discharged on day 4 postoperatively with the drain in
place. It was removed at the outpatient clinic the next
week. Histopathology showed necrotizing acute chole-
cystitis. The stent was removed at ERCP 6 weeks later and
a check cholangiogram showed a normal bile duct with
no filling of any residual cystic duct and no stricture.
During 18 months of follow-up, no delayed sequelae have
occurred.
DISCUSSION
MS is a rare cause of jaundice due to extrinsic compression
of the CHD and is present in approximately 0.35% of chole-
cystectomies.4 Many series report much higher rates; how-
ever, this may represent differing views on what constitutes
Figure 4. The gallbladder (GB) has been dissected from the liver
retrograde, and the liver retractor is in place. The arrow points to
Surgicel (Ethicon, Somerville, NJ, USA) in the gallbladder bed of
the liver.
Figure 3. Computed tomograpic scan showing a calcified stone causing bile duct obstruction with the proximal end of the stent just
below the stone. Residual contrast from the ERCP is present in the gallbladder (Somatom volume zoom, 4 slice, Siemens AG, Erlangen,
Germany).
Acute Mirizzi Syndrome, Kelly MD
JSLS (2009)13:104–109 106a case of MS. Kwon and Inui5 recently reported a prevalence
of 1.2%, but only a third of their patients were jaundiced, and
despite this the majority still underwent open surgery.
Laparoscopic surgery for MS remains controversial with
most authors reporting high conversion rates.5,6 Similarly,
planned open operation for Mirizzi syndrome is accepted
and, in fact, is still advocated by many.7 Many surgeons do
not view conversion as detrimental and therefore do not
persist laparoscopically when cholecystectomy is difficult.
Conversion or an open operation allows the use of pro-
prioception or the touch of the surgeon’s hand and is
generally accepted as a way to improve the safety of any
operation, especially one in which severe inflammation is
present. To replicate this, hand-assisted laparoscopic sur-
gery for MS has been advocated.8 However, open surgery
is associated with significant short- and long-term morbid-
ity, and a difficult operation is not necessarily easier or
safer when performed open.9,10 A degree of tactility is
possible via instruments although not by currently avail-
able robotic systems, and laparoscopic ultrasound is very
useful in stone disease.
It is generally accepted that an increased risk of bile duct
injury exists during surgery for MS, and laparoscopic sur-
gery may increase this risk. Operative cholangiography is
advocated to improve the safety of cholecystectomy, but
an accurate transcystic cholangiogram will not be possible
in MS. A standard techniqu1e in open surgery for the
difficult laparoscopic cholecystectomy was the “fundus-
first” approach. This can be replicated in laparoscopic
surgery by the use of a liver retractor and means that
exposure does not rely on traction on the fundus of the
gallbladder.11 In MS, the gallbladder is often fibrosed and
Figure 6. Incising the bile duct to release the stone.
Figure 7. Choledochoscopy using a 5-mm scope showing a
clear bile duct with the stent visible (insert).
Figure 5. Laparoscopic ultrasound image showing the impacted
stone (arrow) in a thickwalled duct (Aloka Inc., Japan).
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exposure of the hepatobiliary triangle. Also once the gall-
bladder is freed from the liver, the obliterated Calot’s
triangle can be more easily evaluated. The magnified view
combined with modern instrumentation should make the
laparoscopic approach superior in most cases.
ERCP may provide definitive treatment for MS; however,
the impacted stone can create real difficulties. More often,
ERCP is used to make the diagnosis and insert a stent to
alleviate the jaundice and allow planning of an elective
operation. If ERCP is to be used as definitive treatment,
sophisticated techniques may be needed for these cases,
including the use of a “mother and baby scope” and
electrohydraulic or laser lithotripsy.12 In the case de-
scribed herein, I could have tried to break up the stone
with an over the wire mechanical lithotripter, although
engaging the stone in the basket may have been difficult.
Alternatively, a mother and baby scope and contact lith-
otripsy (laser or electrohydraulic) could have been tried
but would not have been possible in my opinion because
the actual CBD was not dilated and may not have taken
the 5-mm baby scope. Any of these sophisticated ERCP
techniques would have required an endoscopic sphinc-
terotomy. Because I was planning to remove the gallblad-
der anyway, I preferred to leave the choledochal sphincter
intact to avoid longer term risk of choledocholithiasis from
a colonized biliary tract and papillary stenosis.13 In this
case, I could not stent the obstruction from below but a
percutaneous transhepatic approach could have been
used. This would have been relatively straightforward as
the hepatic ducts were dilated and might have been a
useful strategy if this patient had been unfit for surgery.
There is purportedly a 5 times higher rate of gallbladder
malignancy in Mirizzi sydrome compared with that in
uncomplicated gallstone disease.14 Prasad et al14 found
5.3% of patients with MS had gallbladder cancer com-
pared with 1% in non-MS cases, and most were diagnosed
on histology after cholecystectomy. If the patient is fit for
surgery, the optimal management of MS should include
cholecystectomy.
The technique described leaves the choledochal
sphincter intact and does not require intraoperative
antegrade stenting or use of t-tubes. In MS as described
herein, it would not have been easy to insert these
tubes properly as the opening is into the cystic duct
rather than the bile duct proper. The preoperative en-
doscopically placed transpapillary stent temporarily
overcame the outflow resistance of the sphincter and
allowed safe primary duct closure although periductal
drainage was needed.
CONCLUSION
In MS, even if an operation is planned, preoperative ERCP
and stenting should be considered because this approach
should simplify and improve the safety of the operation. MS
is rare and each case is unique in its own way. Management
of the individual case will depend on local expertise and the
available equipment. In addition, the fitness of the patient for
surgery and the complexity of the pathology are important
for planning the therapeutic approach. In my opinion, MS
should ideally be treated by a combination of ERCP and
stenting with laparosocopic “fundus first” cholecystectomy.
Stenting overcomes the resistance of the choledochal sphinc-
ter, and even if accurate closure of the opening in a friable
and inflamed duct is not possible, it should avoid the devel-
opment of a significant biliary fistula. Careful planning com-
bined with modern equipment should allow most cases to
be managed without t-tubes, destruction of the choledochal
sphincter, or open surgery.
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